Keith M. Hull

2.4k total citations
29 papers, 1.7k citations indexed

About

Keith M. Hull is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Keith M. Hull has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Pharmacology. Recurrent topics in Keith M. Hull's work include Inflammasome and immune disorders (10 papers), Pharmacology and Obesity Treatment (5 papers) and Regulation of Appetite and Obesity (4 papers). Keith M. Hull is often cited by papers focused on Inflammasome and immune disorders (10 papers), Pharmacology and Obesity Treatment (5 papers) and Regulation of Appetite and Obesity (4 papers). Keith M. Hull collaborates with scholars based in United States, Taiwan and Argentina. Keith M. Hull's co-authors include Daniel L. Kastner, Ivona Aksentijevich, Nitza G. Shoham, Elizabeth Mansfield, Geryl Wood, Michael Centola, Carol A. Wise, Kondi Wong, Harjot Singh and Jae Jin Chae and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The FASEB Journal.

In The Last Decade

Keith M. Hull

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith M. Hull United States 14 1.3k 808 419 225 212 29 1.7k
Leigh D Church United Kingdom 17 537 0.4× 484 0.6× 212 0.5× 209 0.9× 56 0.3× 24 1.1k
Sara Tassi Italy 11 1.1k 0.8× 736 0.9× 423 1.0× 128 0.6× 35 0.2× 12 1.6k
Ann‐Kari Lefvert Sweden 24 343 0.3× 960 1.2× 383 0.9× 243 1.1× 34 0.2× 59 2.0k
Jyothi Nayar United States 14 451 0.3× 609 0.8× 143 0.3× 116 0.5× 73 0.3× 15 1.2k
Laura Tesmer United States 8 322 0.2× 947 1.2× 128 0.3× 385 1.7× 91 0.4× 9 1.6k
Isabelle Allaeys Canada 17 537 0.4× 294 0.4× 204 0.5× 76 0.3× 61 0.3× 32 1.2k
F.A. van de Loo Netherlands 20 604 0.5× 517 0.6× 109 0.3× 539 2.4× 53 0.3× 40 1.6k
George Moxley United States 20 270 0.2× 661 0.8× 91 0.2× 507 2.3× 19 0.1× 37 1.5k
Denise Lasigliè Italy 8 648 0.5× 454 0.6× 292 0.7× 97 0.4× 26 0.1× 11 1.1k
Serbülent Yi̇ği̇t Türkiye 17 324 0.2× 231 0.3× 67 0.2× 204 0.9× 41 0.2× 114 925

Countries citing papers authored by Keith M. Hull

Since Specialization
Citations

This map shows the geographic impact of Keith M. Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith M. Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith M. Hull more than expected).

Fields of papers citing papers by Keith M. Hull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith M. Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith M. Hull. The network helps show where Keith M. Hull may publish in the future.

Co-authorship network of co-authors of Keith M. Hull

This figure shows the co-authorship network connecting the top 25 collaborators of Keith M. Hull. A scholar is included among the top collaborators of Keith M. Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith M. Hull. Keith M. Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hull, Keith M. & Samantha S. Yim. (2012). Regulatory Aspects of New Medicines Targeted at Treatment of Autoimmune Diseases. Clinical Pharmacology & Therapeutics. 91(4). 739–742. 2 indexed citations
2.
Bulua, Ariel C., Douglas Mogul, Ivona Aksentijevich, et al.. (2011). Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study. Arthritis & Rheumatism. 64(3). 908–913. 98 indexed citations
3.
Hurst, Miriam, Keith M. Hull, Dave Nicholls, & Rohan Ameratunga. (2005). Hereditary Periodic Fever Syndrome Sans Fever or Distinct Periodicity Presenting With Psychosis. JCR Journal of Clinical Rheumatology. 11(6). 329–330. 8 indexed citations
4.
Hull, Keith M., Nitza G. Shoham, Jae Jin Chae, Ivona Aksentijevich, & Daniel L. Kastner. (2003). The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Current Opinion in Rheumatology. 15(1). 61–69. 166 indexed citations
5.
Shoham, Nitza G., Michael Centola, Elizabeth Mansfield, et al.. (2003). Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proceedings of the National Academy of Sciences. 100(23). 13501–13506. 358 indexed citations
6.
Hull, Keith M., Elizabeth Drewe, Ivona Aksentijevich, et al.. (2002). The TNF Receptor-Associated Periodic Syndrome (TRAPS). Medicine. 81(5). 349–368. 292 indexed citations
7.
Hull, Keith M., Kondi Wong, Geryl Wood, Wei‐Sing Chu, & Daniel L. Kastner. (2002). Monocytic fasciitis: A newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis & Rheumatism. 46(8). 2189–2194. 61 indexed citations
8.
Aksentijevich, Ivona, Jérôme Galon, Miguel Luz Soares, et al.. (2001). The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic Fevers. The American Journal of Human Genetics. 69(2). 301–314. 234 indexed citations
9.
Hull, Keith M., Lawrence S.C. Griffith, Ralph W. Kuncl, & Fredrick M. Wigley. (2001). A deceptive case of amyloid myopathy: Clinical and magnetic resonance imaging features. Arthritis & Rheumatism. 44(8). 1954–1958. 17 indexed citations
10.
Toro, Jorge R., et al.. (2000). Tumor Necrosis Factor Receptor–Associated Periodic Syndrome. Archives of Dermatology. 136(12). 1487–94. 90 indexed citations
11.
Linakis, James G., Keith M. Hull, Peter G. Lacouture, et al.. (1997). Enhancement of Lithium Elimination by Multiple‐dose Sodium Polystyrene Sulfonate. Academic Emergency Medicine. 4(3). 175–178. 12 indexed citations
12.
Linakis, James G., Keith M. Hull, Peter G. Lacouture, et al.. (1996). Sodium Polystyrene Sulfonate Treatment for Lithium Toxicity: Effects on Serum Potassium Concentrations. Academic Emergency Medicine. 3(4). 333–337. 11 indexed citations
13.
Linakis, James G., et al.. (1995). Effect of Delayed Treatment with Sodium Polystyrene Sulfonate on Serum Lithium Concentrations in Mice. Academic Emergency Medicine. 2(8). 681–685. 10 indexed citations
14.
15.
Hull, Keith M.. (1993). Effect of phenylpropanolamine and related compounds on β-adrenoceptor-induced activation of adenylyl cyclase. Life Sciences. 52(15). 1287–1294. 2 indexed citations
16.
Hull, Keith M., et al.. (1993). Comparison between phenylpropanolamine and structurally related compounds on gastric transit in the rat. Pharmacology Biochemistry and Behavior. 46(2). 411–414. 2 indexed citations
17.
Hull, Keith M., et al.. (1993). Cholestyramine as an adsorbent in acute lindane poisoning: A murine model. Annals of Emergency Medicine. 22(9). 1392–1397. 5 indexed citations
18.
Hull, Keith M. & Timothy J. Maher. (1992). Effects of l-tyrosine on mixed-acting sympathomimetic-induced pressor actions. Pharmacology Biochemistry and Behavior. 43(4). 1047–1052. 7 indexed citations
19.
Hull, Keith M. & Timothy J. Maher. (1991). L-tyrosine fails to potentiate several peripheral actions of the sympathomimetics. Pharmacology Biochemistry and Behavior. 39(3). 755–759. 6 indexed citations
20.
Hull, Keith M. & T. Maher. (1990). L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 403–409. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leigh D Church Breakdown of academic impact, for papers by Sara Tassi Breakdown of academic impact, for papers by Ann‐Kari Lefvert Breakdown of academic impact, for papers by Jyothi Nayar Breakdown of academic impact, for papers by Laura Tesmer Breakdown of academic impact, for papers by Isabelle Allaeys Breakdown of academic impact, for papers by F.A. van de Loo Breakdown of academic impact, for papers by George Moxley Breakdown of academic impact, for papers by Denise Lasigliè Breakdown of academic impact, for papers by Serbülent Yi̇ği̇t
Rankless by CCL
2026